- Home
- XMTR vs OGN Comparison
XMTR vs OGN Comparison
Compare XMTR & OGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XMTR
- OGN
- Stock Information
- Founded
- XMTR 2013
- OGN 1923
- Country
- XMTR United States
- OGN United States
- Employees
- XMTR N/A
- OGN N/A
- Industry
- XMTR Industrial Machinery/Components
- OGN Biotechnology: Pharmaceutical Preparations
- Sector
- XMTR Technology
- OGN Health Care
- Exchange
- XMTR Nasdaq
- OGN Nasdaq
- Market Cap
- XMTR 2.5B
- OGN 2.7B
- IPO Year
- XMTR 2021
- OGN N/A
- Fundamental
- Price
- XMTR $48.83
- OGN $9.25
- Analyst Decision
- XMTR Buy
- OGN Buy
- Analyst Count
- XMTR 11
- OGN 3
- Target Price
- XMTR $37.64
- OGN $17.33
- AVG Volume (30 Days)
- XMTR 775.4K
- OGN 3.3M
- Earning Date
- XMTR 11-04-2025
- OGN 10-30-2025
- Dividend Yield
- XMTR N/A
- OGN 0.86%
- EPS Growth
- XMTR N/A
- OGN N/A
- EPS
- XMTR N/A
- OGN 2.69
- Revenue
- XMTR $603,762,000.00
- OGN $6,281,000,000.00
- Revenue This Year
- XMTR $22.96
- OGN N/A
- Revenue Next Year
- XMTR $17.80
- OGN $0.79
- P/E Ratio
- XMTR N/A
- OGN $3.45
- Revenue Growth
- XMTR 20.19
- OGN N/A
- 52 Week Low
- XMTR $18.59
- OGN $8.01
- 52 Week High
- XMTR $58.03
- OGN $19.05
- Technical
- Relative Strength Index (RSI)
- XMTR 46.64
- OGN 33.08
- Support Level
- XMTR $44.35
- OGN $9.14
- Resistance Level
- XMTR $54.90
- OGN $9.72
- Average True Range (ATR)
- XMTR 2.41
- OGN 0.33
- MACD
- XMTR -0.83
- OGN -0.16
- Stochastic Oscillator
- XMTR 42.46
- OGN 5.10
About XMTR Xometry Inc.
Xometry Inc is engaged in providing AI-enabled manufacturing equipment. Its buyers include engineers, product designers, procurement and supply chain personnel, inventors, and business owners. The manufacturing processes offered by the company include CNC Machining, Injection Molding, Urethane Casting, 3D Printing, and Die Casting. The company is organized into two segments referred to as the U.S. and the International. The majority of its revenue is derived from the U.S. segment.
About OGN Organon & Co.
Organon & Co is a science-based pharmaceutical company that develops and delivers health solutions through a portfolio of prescription therapies within women's health, biosimilars, and established brands. The Company's operations include the following product portfolio: Women's health, Biosimilars and Established medicines. Geographically, it derives a majority of its revenue from Europe and Canada followed by the United States and then Asia Pacific and Japan. The company generates the majority of its revenue from the Established Brands product portfolio.